Intraperitoneal addition of hyaluronan improves peritoneal dialysis efficiency

Area of Science:

• Peritoneal dialysis research
• Biomaterials science
• Renal physiology

Background:

• Hyaluronan (HA) is known to reduce peritoneal fluid absorption.
• The precise impact of varying HA molecular weights and concentrations on this absorption rate remains unclear.

Purpose of the Study:

• To investigate the effects of different hyaluronan molecular weights and concentrations on peritoneal fluid absorption rate.
• To determine if hyaluronan can mitigate decreased ultrafiltration associated with high dialysate fill volumes.

Main Methods:

• Male Sprague-Dawley rats underwent 4-hour peritoneal dwells with various HA molecular weights (85 kD to 4 MD) and concentrations (0.01% to 0.5%).
• Peritoneal fluid absorption was measured using 131I albumin as a volume marker.
• Studies also included high dialysate fill volumes to assess HA's effect under those conditions.

Main Results:

• A 0.01% concentration of HA significantly decreased peritoneal fluid absorption rate (K(E)) by 22%.
• Higher HA molecular weights and concentrations led to more pronounced decreases in absorption.
• HA addition generally increased net ultrafiltration, primarily by reducing K(E), and could counteract volume-induced ultrafiltration decline.

Conclusions:

• Intraperitoneal HA enhances net fluid removal by decreasing peritoneal fluid absorption, with efficacy dependent on molecular weight and concentration.
• HA can prevent reduced net ultrafiltration caused by increased dialysate fill volumes.
• High molecular weight HA, even at low concentrations, may reduce transcapillary ultrafiltration (Qu), but this effect is not observed at high HA concentrations.